78 results on '"Hajjar, Roger J"'
Search Results
2. Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts
3. Direct reprogramming induces vascular regeneration post muscle ischemic injury
4. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy
5. Child Health Promotion in Underserved Communities: The FAMILIA Trial
6. Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
7. Role of the PRC2-Six1-miR-25 signaling axis in heart failure
8. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension
9. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction
10. Acute Left Ventricular Unloading Reduces Atrial Stretch and Inhibits Atrial Arrhythmias
11. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes
12. CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response
13. Optimizing Cardiac Delivery of Modified mRNA
14. Increased Afterload Following Myocardial Infarction Promotes Conduction-Dependent Arrhythmias That Are Unmasked by Hypokalemia
15. A series of robust genetic indicators for definitive identification of cardiomyocytes
16. Post-translational Modifications in Heart Failure: Small Changes, Big Impact
17. Mitigation of myocardial fibrosis by molecular cardiac surgery–mediated gene overexpression
18. Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias
19. Altered Myocardial Calcium Cycling and Energetics in Heart Failure—A Rational Approach for Disease Treatment
20. Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias
21. Preclinical animal models for testing iPSC/ESC-based heart therapy
22. Targeted Gene Therapy for the Treatment of Heart Failure
23. Pericardial Fluid Exosomes: A New Material to Treat Cardiovascular Disease
24. Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
25. Cardiac Gene Therapy
26. Gene therapy for heart failure
27. Refilling intracellular calcium stores
28. Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
29. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
30. Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure
31. Mitral Regurgitation Augments Post-Myocardial Infarction Remodeling: Failure of Hypertrophic Compensation
32. Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure
33. Chapter 16 - Gene and protein-based therapies for improving cardiac performance and regeneration
34. Comparison of nonuniform rotational distortion between mechanical IVUS and OCT using a phantom model
35. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins
36. CXCR4 modulates contractility in adult cardiac myocytes
37. Tracking Stem Cells in the Cardiovascular System
38. Transgenic Models of Heart Failure: Elucidation of the Molecular Mechanisms of Heart Disease
39. Targeting Genes and Cells in the Progression to Heart Failure
40. In vivo volumetric analysis of coronary stent using optical coherence tomography with a novel balloon occlusion-flushing catheter: A comparison with intravascular ultrasound
41. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: Implications for herceptin-induced cardiomyopathy
42. Gene transfer in cardiac myocytes
43. 30 - Regeneração Cardiovascular e Terapia Genética
44. Gene therapy for the treatment of heart failure—calcium signaling
45. Genetic editing of dysfunctional myocardium
46. Modulating signaling pathways in hypertrophy and heart failure by gene transfer
47. Effects of Na+/Ca2+-exchanger Overexpression on Excitation–contraction Coupling in Adult Rabbit Ventricular Myocytes
48. Gene therapy in heart failure
49. Cardiac signal transduction
50. 30 - Regeneración cardiovascular y terapia génica
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.